(Total Views: 332)
Posted On: 07/03/2021 6:26:42 PM
Post# of 30067
MANF is ...or could be stunning. But still long term.
LymPro could be quicker than expected. With the relationships Todos/ Gerald is building Ex-US things could move quickly. I'm not saying that's the case ,but I am saying the relationships Gerald is building via TODOS plays right into revenue across the board for DX testing.
Also, with the idea that ALZ is a root cancer disease that falls in line with this administration especially with the idea it possibly could be enhanced or speed up via COVID.
As for Eltop, that is not with Healixa. It was removed from the deal and is with Amarantus.
Right time?
LymPro could be quicker than expected. With the relationships Todos/ Gerald is building Ex-US things could move quickly. I'm not saying that's the case ,but I am saying the relationships Gerald is building via TODOS plays right into revenue across the board for DX testing.
Also, with the idea that ALZ is a root cancer disease that falls in line with this administration especially with the idea it possibly could be enhanced or speed up via COVID.
As for Eltop, that is not with Healixa. It was removed from the deal and is with Amarantus.
Right time?
(0)
(0)
